Enovis Corp
ENOV26.840USD
+0.530+2.01%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
1.53BMarket Cap
LossP/E TTM
More Details of Enovis Corp Company
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Enovis Corp Info
Ticker SymbolENOV
Company nameEnovis Corp
IPO dateMay 08, 2008
CEOMcdonald (Damien)
Number of employees7367
Security typeOrdinary Share
Fiscal year-endMay 08
Address2711 Centerville Road
CityWILMINGTON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code19808
Phone13022529160
Websitehttps://www.enovis.com/
Ticker SymbolENOV
IPO dateMay 08, 2008
CEOMcdonald (Damien)
Company Executives of Enovis Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
114.51K
+9.57%
Mr. Damien Mcdonald
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
102.75K
+6.71%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
35.79K
-0.90%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+30.46%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+47.89%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+76.12%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
10.52K
+168.36%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
10.52K
+168.36%
Mr. Philip A. Okala
Mr. Philip A. Okala
Independent Director
Independent Director
--
--
Ms. Angela S. Lalor
Ms. Angela S. Lalor
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
114.51K
+9.57%
Mr. Damien Mcdonald
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
102.75K
+6.71%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
35.79K
-0.90%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+30.46%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+47.89%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+76.12%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
International Reconstructive
144.48M
25.59%
U.S. Reconstructive
129.49M
22.94%
U.S. Bracing & Support
120.85M
21.41%
International P&R
98.90M
17.52%
U.S. Other P&R
70.82M
12.55%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
International Reconstructive
144.48M
25.59%
U.S. Reconstructive
129.49M
22.94%
U.S. Bracing & Support
120.85M
21.41%
International P&R
98.90M
17.52%
U.S. Other P&R
70.82M
12.55%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.92%
The Vanguard Group, Inc.
11.35%
American Century Investment Management, Inc.
8.27%
Dimensional Fund Advisors, L.P.
5.20%
Davenport Asset Management
4.91%
Other
56.36%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.92%
The Vanguard Group, Inc.
11.35%
American Century Investment Management, Inc.
8.27%
Dimensional Fund Advisors, L.P.
5.20%
Davenport Asset Management
4.91%
Other
56.36%
Shareholder Types
Shareholders
Proportion
Investment Advisor
63.50%
Investment Advisor/Hedge Fund
30.16%
Hedge Fund
16.30%
Research Firm
4.93%
Individual Investor
1.59%
Pension Fund
1.18%
Bank and Trust
1.18%
Family Office
0.07%
Sovereign Wealth Fund
0.05%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
617
68.12M
125.63%
--
2025Q3
641
68.12M
128.26%
-1.19M
2025Q2
651
69.44M
130.24%
+2.07M
2025Q1
629
67.38M
125.09%
-4.06M
2024Q4
625
63.48M
125.04%
+1.28M
2024Q3
599
62.09M
124.13%
-57.94K
2024Q2
602
61.71M
121.92%
+2.05M
2024Q1
635
59.58M
125.47%
-9.23M
2023Q4
647
58.62M
120.02%
+2.97M
2023Q3
636
55.66M
121.59%
+429.23K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
8.02M
14.03%
+1.50M
+22.95%
Jun 30, 2025
The Vanguard Group, Inc.
6.37M
11.14%
+288.04K
+4.74%
Jun 30, 2025
American Century Investment Management, Inc.
4.74M
8.29%
+1.21M
+34.39%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.92M
5.11%
-7.00K
-0.24%
Jun 30, 2025
Davenport Asset Management
2.76M
4.82%
-86.99K
-3.06%
Jul 31, 2025
Dorsey Asset Management LLC
2.55M
4.47%
+2.55M
--
Jun 30, 2025
State Street Investment Management (US)
2.49M
4.35%
+592.50K
+31.27%
Jun 30, 2025
Hood River Capital Management LLC
1.74M
3.04%
+292.95K
+20.31%
Jun 30, 2025
River Road Asset Management, LLC
1.44M
2.52%
+48.04K
+3.45%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
1.83%
Invesco S&P SmallCap Health Care ETF
1.09%
Invesco S&P SmallCap 600 Pure Value ETF
0.45%
State Street SPDR S&P 600 Small Cap Value ETF
0.25%
iShares S&P Small-Cap 600 Value ETF
0.24%
iShares U.S. Medical Devices ETF
0.21%
Humankind US Stock ETF
0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
0.18%
Avantis US Small Cap Equity ETF
0.18%
Invesco S&P SmallCap 600 Revenue ETF
0.16%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion1.83%
Invesco S&P SmallCap Health Care ETF
Proportion1.09%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.45%
State Street SPDR S&P 600 Small Cap Value ETF
Proportion0.25%
iShares S&P Small-Cap 600 Value ETF
Proportion0.24%
iShares U.S. Medical Devices ETF
Proportion0.21%
Humankind US Stock ETF
Proportion0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
Proportion0.18%
Avantis US Small Cap Equity ETF
Proportion0.18%
Invesco S&P SmallCap 600 Revenue ETF
Proportion0.16%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Date
Type
Ratio
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
FAQs
Who are the top five shareholders of Enovis Corp?
The top five shareholders of Enovis Corp are:
BlackRock Institutional Trust Company, N.A. holds 8.02M shares, accounting for 14.03% of the total shares.
The Vanguard Group, Inc. holds 6.37M shares, accounting for 11.14% of the total shares.
American Century Investment Management, Inc. holds 4.74M shares, accounting for 8.29% of the total shares.
Dimensional Fund Advisors, L.P. holds 2.92M shares, accounting for 5.11% of the total shares.
Davenport Asset Management holds 2.76M shares, accounting for 4.82% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 8.02M shares, accounting for 14.03% of the total shares.
The Vanguard Group, Inc. holds 6.37M shares, accounting for 11.14% of the total shares.
American Century Investment Management, Inc. holds 4.74M shares, accounting for 8.29% of the total shares.
Dimensional Fund Advisors, L.P. holds 2.92M shares, accounting for 5.11% of the total shares.
Davenport Asset Management holds 2.76M shares, accounting for 4.82% of the total shares.
What are the top three shareholder types of Enovis Corp?
The top three shareholder types of Enovis Corp are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
American Century Investment Management, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
American Century Investment Management, Inc.
How many institutions hold shares of Enovis Corp (ENOV)?
As of 2025Q4, 617 institutions hold shares of Enovis Corp, with a combined market value of approximately 68.12M, accounting for 125.63% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -2.63%.
What is the biggest source of revenue for Enovis Corp?
In FY2025Q2, the International Reconstructive business generated the highest revenue for Enovis Corp, amounting to 144.48M and accounting for 25.59% of total revenue.
